Molina Healthcare Q2 2024 Adj EPS $5.86 Beats $5.55 Estimate, Sales $9.880B Beat $9.746B Estimate
Portfolio Pulse from Benzinga Newsdesk
Molina Healthcare (NYSE:MOH) reported Q2 2024 adjusted EPS of $5.86, beating the estimate of $5.55. Sales were $9.880 billion, surpassing the $9.746 billion estimate and marking an 18.65% increase from the same period last year.
July 24, 2024 | 8:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Molina Healthcare reported strong Q2 2024 results, with EPS and sales both beating analyst estimates. The company's sales also showed significant year-over-year growth.
The strong earnings and sales performance, along with significant year-over-year growth, are likely to positively impact Molina Healthcare's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100